Formulated specifically for perimenopausal and menopausal women, Noctera by Bonafide Health is a daily sleep support solution designed to work with the body's natural sleep patterns to help improve overall sleep quality impacted by hormonal changes. This non-sedative, hormone-free sleep product is meant to be used daily and continuously, rather than as an on-demand treatment, so that ingredients like GABA, L-theanine, magnesium glycinate, and SAMe can maximize sleep benefits.
This supplement for balancing the body's sleep signals doesn't just help to improve the quality of sleep, but also reduces sleep disturbances and boosts daytime energy. A randomized, double-blind, placebo-controlled trial showed that Noctera significantly enhanced sleep quality in perimenopausal and postmenopausal women experiencing moderate-to-severe sleep issues.
What Makes This Trend Stand Out
- Targeted Menopause Supplements
- A rise in formulations tailored to perimenopausal and menopausal physiology enables products that specifically address hormonal sleep disruptions rather than generic sleep aid usage.
- Daily Non-sedative Chronobiotics
- Products designed for continuous, non-sedative administration aim to realign natural sleep signals over time through ingredients like GABA, magnesium glycinate, and L-theanine.
- Clinical-trial Backed Wellness Products
- Evidence from randomized, double-blind, placebo-controlled studies is increasingly used to validate efficacy claims and differentiate brands in the supplement market.
Sectors Adopting This
- Women's Health Supplements
- Manufacturers focused on female-specific formulations are positioned to capture demand for hormone-free, targeted sleep aids that address menopausal symptomatology.
- Digital Health and Telemedicine
- Remote care platforms and telehealth services are integrating symptom tracking and personalized supplement recommendations for midlife women experiencing sleep disturbances.
- Nutraceutical Manufacturing and Supply Chain
- Ingredient sourcing, quality control, and scalable production capabilities become critical as demand rises for clinically tested, continuously used sleep-support supplements.
